New Stock First Day | Tiansheng Medical (01609) Debuts on the Market, Opening 192.39% higher in the morning. The company is a domestic provider of sports medicine implants and equipment.

Tianxing Medical (01609) made its debut on the stock market. The announcement shows that the price per share is 98.5 Hong Kong dollars, with a total of 8.4219 million shares issued, and 50 shares per lot, raising a net amount of approximately 758.4 million Hong Kong dollars. It is worth mentioning that the stock received 300,700 applications for public sale in Hong Kong, with 16,800 accepted, oversubscribed by 78,231.3 times. As of the time of writing, the stock has risen by 192.39% to 288 Hong Kong dollars, with a turnover of 458 million Hong Kong dollars. According to public information, Tianxing Medical is a leading provider of comprehensive solutions in sports medicine in China, focusing on the research, development, production, and commercialization of sports medicine implants, surgical equipment, and related consumables. The company's products are mainly used for the repair and reconstruction of soft tissue injuries in joints such as shoulders, knees, hips, and ankles, and also provide comprehensive solutions for sports rehabilitation and prevention. According to data from Zhushi Consulting, Tianxing Medical is the fourth largest sports medicine implant and equipment supplier in China by sales revenue in 2024, with a market share of 6.5%. In terms of performance, the company is expected to achieve revenue and net profit attributable to shareholders of 403 million and 137 million yuan respectively in 2025.